# Genetic and Environmental Factors Shaping Hearing Loss: Xenobiotics, Mechanisms and Translational Perspectives

**Authors:** Francisco Esteves, Helena Caria

PMC · DOI: 10.3390/jox16010027 · Journal of Xenobiotics · 2026-02-05

## TL;DR

This review explores how genes and environmental factors work together to cause hearing loss, focusing on mechanisms like redox imbalance and inflammation.

## Contribution

The paper provides a comprehensive review of gene–environment interactions in hearing loss, emphasizing translational strategies for precision risk assessment and otoprotection.

## Key findings

- Environmental xenobiotics like heavy metals and pesticides contribute to hearing loss through oxidative stress and mitochondrial dysfunction.
- Genetic susceptibility combined with environmental exposures disrupts cochlear homeostasis via inflammatory and redox pathways.
- Translational approaches aim to develop precision-based interventions and otoprotective strategies based on gene–environment interactions.

## Abstract

The central mechanistic hypothesis underlying multifactorial hearing loss posits that genetic susceptibility and environmental exposures act synergistically to disrupt cochlear homeostasis through redox imbalance, mitochondrial dysfunction, and pro-inflammatory mechanisms. This gene–environment paradigm has significant translational implications: elucidating the molecular crosstalk between genetic variants and environmental factors may enable precision risk stratification and the development of targeted otoprotective strategies. The present review provides a comprehensive examination of the major determinants implicated in hearing loss. The manuscript is organized into six main sections that encompass the most relevant domains of current research. First, it offers (I) an overview of epidemiological patterns and the multifactorial nature of hearing impairment. This is followed by (II) a background synthesis of the complex genetic architecture underlying hearing loss. Next, the authors present (III) an outline of environmental determinants and exposure profiles associated with auditory dysfunction, highlighting prominent pollutant/xenobiotic classes (e.g., organic solvents and volatile aromatic hydrocarbons, heavy metals, pesticides, and especially organophosphates and persistent organochlorine compounds), followed by (IV) an analysis of oxidative stress, mitochondrial impairment, and inflammatory pathways involved in cochlear injury. Subsequently, (V) translational perspectives and integrated therapeutic approaches are discussed, with emphasis on epidemiological prevention and precision-based interventions. Finally, (VI) this review addresses current challenges and future directions in elucidating gene–environment interactions in hearing loss.

## Linked entities

- **Diseases:** hearing loss (MONDO:0005365), hearing impairment (MONDO:0005365)

## Full-text entities

- **Genes:** CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, Gjb2 (gap junction protein, beta 2) [NCBI Gene 14619] {aka Cnx26, Cx26, Cxne, Gjb-2}, GRHL2 (grainyhead like transcription factor 2) [NCBI Gene 79977] {aka BOM, DFNA28, ECTDS, PPCD4, TFCP2L3}, WFS1 (wolframin ER transmembrane glycoprotein) [NCBI Gene 7466] {aka CTRCT41, WFRS, WFS, WFSL}, SLC26A4 (solute carrier family 26 member 4) [NCBI Gene 5172] {aka DFNB4, EVA, PDS, TDH2B}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, RNR1 (s-rRNA) [NCBI Gene 4549] {aka MTRNR1}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, KCNQ4 (potassium voltage-gated channel subfamily Q member 4) [NCBI Gene 9132] {aka DFNA2, DFNA2A, KV7.4}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, Nqo1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 24314] {aka Dia4}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, CLDN14 (claudin 14) [NCBI Gene 23562] {aka DFNB29}, STRC (stereocilin) [NCBI Gene 161497] {aka DFNB16}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], HDAC1 (histone deacetylase 1) [NCBI Gene 3065] {aka GON-10, HD1, KDAC1, RPD3, RPD3L1}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, TBC1D24 (TBC1 domain family member 24) [NCBI Gene 57465] {aka DEE16, DFNA65, DFNB86, DOORS, EIEE16, EIM}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, GJB2 (gap junction protein beta 2) [NCBI Gene 2706] {aka BAPS, CX26, DFNA3, DFNA3A, DFNB1, DFNB1A}, POLG (DNA polymerase gamma, catalytic subunit) [NCBI Gene 5428] {aka MIRAS, MTDPS4A, MTDPS4B, PEO, POLG1, POLGA}, GSTM1 (glutathione S-transferase mu 1) [NCBI Gene 2944] {aka GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1}, GJB6 (gap junction protein beta 6) [NCBI Gene 10804] {aka CX30, DFNA3, DFNA3B, DFNB1B, ECTD2, ED2}, TECTA (tectorin alpha) [NCBI Gene 7007] {aka DFNA12, DFNA8, DFNB21}, GPX1 (glutathione peroxidase 1) [NCBI Gene 2876] {aka GPXD, GSHPX1}, OTOF (otoferlin) [NCBI Gene 9381] {aka AUNB1, DFNB6, DFNB9, FER1L2, NSRD9}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, UCN (urocortin) [NCBI Gene 7349] {aka UCN1, UI, UROC}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Slc26a4 (solute carrier family 26, member 4) [NCBI Gene 23985] {aka Pds, pendrin}, POU3F4 (POU class 3 homeobox 4) [NCBI Gene 5456] {aka BRAIN-4, BRN-4, BRN4, DFN3, DFNX2, OCT-9}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317] {aka APAF-1, CED4}, PPIG (peptidylprolyl isomerase G) [NCBI Gene 9360] {aka CARS-Cyp, CYP, SCAF10, SRCyp}, GRM7 (glutamate metabotropic receptor 7) [NCBI Gene 2917] {aka GLUR7, GPRC1G, MGLU7, MGLUR7, NEDSHBA, PPP1R87}, ATP2B2 (ATPase plasma membrane Ca2+ transporting 2) [NCBI Gene 491] {aka DFNA82, PMCA2, PMCA2a, PMCA2i}, POU4F3 (POU class 4 homeobox 3) [NCBI Gene 5459] {aka BRN3C, DFNA15, DFNA42, DFNA52}, KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1) [NCBI Gene 3753] {aka ISK, JLNS, JLNS2, LQT2/5, LQT5, MinK}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, TRNS1 (tRNA-Ser) [NCBI Gene 4574] {aka MTTS1}, EYA4 (EYA transcriptional coactivator and phosphatase 4) [NCBI Gene 2070] {aka CMD1J, DFNA10}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Hmox1 (heme oxygenase 1) [NCBI Gene 24451] {aka HEOXG, Heox, Hmox, Ho-1, Ho1, hsp32}, Otof (otoferlin) [NCBI Gene 83762], MYO6 (myosin VI) [NCBI Gene 4646] {aka DFNA22, DFNB37}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, COCH (cochlin) [NCBI Gene 1690] {aka COCH-5B2, COCH5B2, DFNA9, DFNB110}, Mir34a (microRNA 34a) [NCBI Gene 723848] {aka Mirn34a, mir-34a, mmu-mir-34a}, CAT (catalase) [NCBI Gene 847], Gpx1 (glutathione peroxidase 1) [NCBI Gene 24404] {aka GSHPx, GSHPx-1}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}
- **Diseases:** age-dependent neuronal dysfunction (MESH:D003859), hypersensitivity (MESH:D004342), Pendred syndrome (MESH:C536648), auditory pathology (MESH:D005598), vertigo (MESH:D014717), auditory and vestibular impairment (MESH:D015837), febrile (MESH:D000071072), calcium (MESH:D002128), smoking (MESH:D015208), membrane (MESH:D015433), presbycusis (MESH:D011304), auditory nerve degeneration (MESH:D009410), sensory damage (MESH:D009477), autoimmune inner-ear pathologies (MESH:D007759), autosomal recessive nonsyndromic deafness (MESH:C580334), high-frequency hearing loss (MESH:D006316), autosomal recessive deafness (MESH:C564609), cells (MESH:D002292), NIHL (MESH:D006317), X linked deafness (MESH:C536424), acoustic (MESH:D009464), necrosis (MESH:D009336), immune dysregulation (OMIM:614878), Hearing Loss (MESH:D034381), ARHI (MESH:C567305), metabolic disease (MESH:D008659), sensorineural decline (MESH:D006319), auditory nerve injury (MESH:D000080902), DFNA (MESH:C538197), mitochondrial (MESH:D028361), syndromic and non-syndromic hearing loss (MESH:C537845), HHL (MESH:D009386), loss (MESH:D016388), metabolic syndrome (MESH:D024821), injury to (MESH:D014947), mitochondrial defects (MESH:C565376), cochlear toxicity (MESH:D000160), Inflammatory (MESH:D007249), endolymphatic hydrops (MESH:D018159), ARHL (MESH:D010024), EVA (OMIM:600791), Ototoxic (MESH:D006311), mitochondrial disruption (MESH:D019958), cytotoxic (MESH:D064420), sensory disorders (MESH:D012678), Cochlear Damage (MESH:D015834), congenital (MESH:D008209), tinnitus (MESH:D014012), auditory damage (MESH:D001304), Deafness (MESH:D003638), hearing decline (MESH:D060825), mitochondrial failure (MESH:D051437), neurotoxic (MESH:D020258)
- **Chemicals:** panobinostat (MESH:D000077767), lipid (MESH:D008055), styrene (MESH:D020058), glutathione (MESH:D005978), peroxynitrite (MESH:D030421), sodium butyrate (MESH:D020148), ATP (MESH:D000255), water (MESH:D014867), benzene (MESH:D001554), phospholipids (MESH:D010743), hydroxyl radical (MESH:D017665), ROS (MESH:D017382), chloride (MESH:D002712), calcium (MESH:D002118), Heavy metals (MESH:D019216), glucose (MESH:D005947), kanamycin (MESH:D007612), nitric oxide (MESH:D009569), 8-oxo-dG (MESH:D000080242), gentamicin (MESH:D005839), cadmium (MESH:D002104), N-acetylcysteine (MESH:D000111), resveratrol (MESH:D000077185), NAD+ (MESH:D009243), lead (MESH:D007854), SAHA (MESH:D000077337), oxygen (MESH:D010100), belinostat (MESH:C487081), mercury (MESH:D008628), hydroquinones (MESH:D006873), aminoglycoside (MESH:D000617), K+ (MESH:D011188), organophosphates (MESH:D010755), hydrogen peroxide (MESH:D006861), OP insecticides (-), superoxide (MESH:D013481), trichloroethylene (MESH:D014241), ethylbenzene (MESH:C004912), quinones (MESH:D011809), organochlorine compounds (MESH:D006843), MDA (MESH:D008315), bicarbonate (MESH:D001639), CoQ10 (MESH:C024989), sulforaphane (MESH:C016766), mito-TEMPO (MESH:C555916), toluene (MESH:D014050), chlorpyrifos (MESH:D004390), xylene (MESH:D014992), bardoxolone-methyl (MESH:C445068), furosemide (MESH:D005665)
- **Species:** Cavia porcellus (domestic guinea pig, species) [taxon 10141], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** 35delG, c.1615-2A>G, 1555A > G, c.918+2T>C, Ser326Cys, c.1544T > C, p.Glu1342Lys, c.4024G > A, m.3243 A > G, Pro198Leu, V37I, c.593C > T, 35delG or 167delT, R75W, p.Pro187Ser, c.2485C > T, 167delT, p.Arg1825Trp, Rs1894720, Rs113288603, V16A, m.1494C > T, c.5473C > T, IVS14-2A>G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921957/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921957/full.md

## References

335 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921957/full.md

---
Source: https://tomesphere.com/paper/PMC12921957